StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report released on Tuesday. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
Shares of BLPH opened at $0.06 on Tuesday. The stock has a fifty day simple moving average of $0.05 and a two-hundred day simple moving average of $0.05. The company has a market capitalization of $673,873.00, a PE ratio of -0.07 and a beta of 0.67. Bellerophon Therapeutics has a 52-week low of $0.03 and a 52-week high of $11.15.
About Bellerophon Therapeutics
See Also
- Five stocks we like better than Bellerophon Therapeutics
- Dividend Payout Ratio Calculator
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Hilton Demonstrates Asset Light is Right for Investors
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
